IMUX Stock Analysis: Buy, Sell, or Hold?
IMUX - Immunic, Inc. Common Stock
$14.72
-0.35 (-2.32%)
▼
5d:
+7.37%
30d:
+12.8%
90d:
+1077.6%
BUY
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When IMUX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IMUX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: IMUX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: IMUX is currently trading at $14.72, which is considered slightly high relative to its 30-day fair value range of $12.34 to $14.72.
Technical Outlook: Technically, IMUX is in a strong uptrend. Immediate support is located at $11.70, while resistance sits at $15.77.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $44.67 (+196.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMUX is in a strong uptrend. Immediate support is located at $11.70, while resistance sits at $15.77.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $44.67 (+196.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$12.34 -
$14.72
Company Quality Score
52/100
(HOLD)
Options IV Signal
36th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
67.5%
All Signals
- NEUTRAL: Options fairly priced (IV 36th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 196.4% below Wall St target ($44.67)
Trading Range Analysis
30-Day Trading Range
$12.34 -
$14.72
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$2.38
(16.2%)
Support & Resistance Levels
Support Level
$11.70
Resistance Level
$15.77
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.25
Wall Street Target
$44.67
(+196.4%)
Share & Embed Analysis
Last updated: June 24, 2026 2:13 PM ET
Data refreshes hourly during market hours. Next update: 3:13 PM
Data refreshes hourly during market hours. Next update: 3:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMUX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 57 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 58 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
